Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

BACKGROUND/AIM: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become the standard approach for patients with relapsed/refractory Hodgkin’s lymphoma (HL) or non-Hodgkin’s lymphoma (NHL). In this study, we report the outcome of the mitoxantrone-melphalan conditioni...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Turk J Med Sci
Main Authors: OKAY, Müfide, BÜYÜKAŞIK, Yahya, DEMİROĞLU, Haluk, MALKAN, Ümit Yavuz, ÇİFTÇİLER, Rafiye, ALADAĞ, Elifcan, AKSU, Salih, HAZNEDAROĞLU, İbrahim Celalettin, SAYINALP, Nilgün, ÖZCEBE, Osman İlhami, GÖKER, Hakan
Formato: Artigo
Idioma:Inglês
Publicado: The Scientific and Technological Research Council of Turkey 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7018231/
https://ncbi.nlm.nih.gov/pubmed/31293116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1809-36
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares